| Financial Year |
March 31 2023 |
| Monetary Funds |
12,756,975,380.19 |
| Held-for-trading Financial Assets |
1,001,392,602.74 |
| Notes Receivable |
310,356,773.27 |
| Accounts Receivable |
7,908,693,764.36 |
| Advances to Suppliers |
280,150,131.15 |
| Other Receivables |
95,210,436.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,579,370,071.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,240,212.95 |
| Total Current Assets |
29,310,547,627.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,427,093,340.27 |
| Under-construction Projects |
814,405,670.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
844,973,412.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
709,534,265.25 |
| Other Non-Current Assets |
173,421,215.21 |
| Sub-Total of Non-Current Assets |
6,969,427,903.52 |
| Total Assets |
36,279,975,531.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,943,427,231.48 |
| Accounts Payable |
10,548,167,093.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
340,418,502.29 |
| Taxes Payable |
166,824,452.95 |
| Interest Payable |
-- |
| Dividend Payable |
209,200,000.00 |
| Other payables |
3,067,240,215.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,118,414,394.65 |
| Sub-Total of Current Liabilities |
20,952,831,483.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,240,846.74 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
414,494,271.43 |
| Total Liabilities |
21,367,325,754.80 |
| Paid-In Capital(Or Share Stock) |
1,174,869,360.00 |
| Capital Surplus |
4,930,027,593.24 |
| Surplus Reserve |
917,126,032.35 |
| LESS:Treasury Stock |
75,105,912.41 |
| Undistributed Profits |
7,014,689,116.31 |
| Minority Stockholder's Interest |
947,052,250.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,965,597,525.98 |
| Owner's Equity（Stockholder's Equity） |
14,912,649,776.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,279,975,531.36 |
